Table 1.
General Characteristics of Patients With Cystic Fibrosis Included in the Study
| Patient Characteristics | Data |
|---|---|
| Sex (N = 103) | |
| Male | 54 (52.4) |
| Age group, y | |
| 0–4 | 23 (22.3) |
| 5–9 | 35 (34.0) |
| 10–14 | 26 (25.2) |
| ≥ 15 | 19 (18.4) |
| Degree of obstruction by FEV1 value (n = 66) | |
| Very severe | 10 (15.2) |
| Severe | 8 (12.1) |
| Moderately severe | 3 (4.5) |
| Moderate | 6 (9.1) |
| Mild | 10 (15.2) |
| Normal | 29 (43.9) |
| Bacteria colonization (n = 101) | |
| Staphylococcus aureus | 91 (90.1) |
| Pseudomonas aeruginosa | 62 (61.4) |
| Median age (IQR), y | 8.9 (8.1) |
| Median Shwachman-Kulczycki score (IQR) | 75 (20) |
| Median BMI (IQR) | 16.0 (3.1) |
| Median % predicted FEV1 (IQR) | 73.8 (45.8) |
| Visits characteristics | |
| Oxygen saturation (n = 398 visits) | |
| < 85% | 7 (1.8) |
| 85%–89% | 37 (9.3) |
| 90%–92% | 42 (10.6) |
| > 92% | 312 (78.4) |
| FEV1 decrease > 10% (n = 161 visits) | 31 (19.3) |
| Signs or symptoms (n = 408 visits) | |
| Fever | 49 (12) |
| Increased sputum production | 139 (34.1) |
| Increased cough intensity | 335 (82.1) |
| Change in sputum | 76 (18.6) |
| Worsening dyspnea | 82 (20.1) |
| Loss of appetite | 54 (13.2) |
Data are presented as No. (%) unless otherwise noted. IQR = interquartile range.